IL114271A0 - Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof - Google Patents
Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereofInfo
- Publication number
- IL114271A0 IL114271A0 IL11427195A IL11427195A IL114271A0 IL 114271 A0 IL114271 A0 IL 114271A0 IL 11427195 A IL11427195 A IL 11427195A IL 11427195 A IL11427195 A IL 11427195A IL 114271 A0 IL114271 A0 IL 114271A0
- Authority
- IL
- Israel
- Prior art keywords
- analogs
- intermediates
- preparation
- acetic acids
- oxophthalazinyl acetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/350,997 US4954629A (en) | 1989-05-11 | 1989-05-11 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
IL9430195 | 1995-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL114271A0 true IL114271A0 (en) | 1995-10-31 |
Family
ID=23379152
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL114271A IL114271A (en) | 1989-05-11 | 1990-05-06 | Oxophthalazinic acid derivatives Acetic acid |
IL9430190A IL94301A (en) | 1989-05-11 | 1990-05-06 | Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them |
IL11427195A IL114271A0 (en) | 1989-05-11 | 1995-06-22 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL114271A IL114271A (en) | 1989-05-11 | 1990-05-06 | Oxophthalazinic acid derivatives Acetic acid |
IL9430190A IL94301A (en) | 1989-05-11 | 1990-05-06 | Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them |
Country Status (30)
Country | Link |
---|---|
US (1) | US4954629A (xx) |
EP (1) | EP0397350B1 (xx) |
JP (1) | JPH035479A (xx) |
KR (1) | KR920006419B1 (xx) |
CN (1) | CN1025855C (xx) |
AR (1) | AR246968A1 (xx) |
AT (1) | ATE103913T1 (xx) |
AU (2) | AU618898B2 (xx) |
BG (1) | BG50609A3 (xx) |
CA (1) | CA2016504C (xx) |
CZ (1) | CZ281213B6 (xx) |
DD (1) | DD294257A5 (xx) |
DE (1) | DE69007846T2 (xx) |
DK (1) | DK0397350T3 (xx) |
EG (1) | EG19082A (xx) |
ES (1) | ES2063265T3 (xx) |
FI (1) | FI93959C (xx) |
HU (1) | HU212304B (xx) |
IE (1) | IE62591B1 (xx) |
IL (3) | IL114271A (xx) |
MX (2) | MX167455B (xx) |
NO (1) | NO177708C (xx) |
NZ (1) | NZ233597A (xx) |
PH (1) | PH26567A (xx) |
PL (1) | PL164427B1 (xx) |
PT (1) | PT93985B (xx) |
RO (1) | RO107256B1 (xx) |
RU (1) | RU2014333C1 (xx) |
YU (1) | YU91290A (xx) |
ZA (1) | ZA903565B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
IL124236A (en) * | 1997-05-05 | 2003-01-12 | Pfizer | Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor |
EP0982306A3 (en) * | 1998-08-21 | 2000-07-05 | Pfizer Products Inc. | Polymorph of zopolrestat monohydrate |
US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
SI3597650T1 (sl) * | 2010-07-16 | 2023-02-28 | The Trustees Of Columbia University In The City Of New York | Inhibitorji aldoza reduktaze in uporabe le-teh |
CN102558184B (zh) * | 2011-12-30 | 2014-07-16 | 西南大学 | 酞嗪类衍生物的合成方法 |
CN102702108A (zh) * | 2012-06-27 | 2012-10-03 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
CN102863393A (zh) * | 2012-09-26 | 2013-01-09 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
BR112018076244A2 (pt) | 2016-06-21 | 2019-03-26 | The Trustees Of Columbia University In The City Of New York | inibidores da aldose redutase e métodos de uso destes |
RU2020107188A (ru) | 2017-07-28 | 2021-08-30 | Эпплайд Терапьютикс Инк. | Композиции и способы лечения галактоземии |
EP3947391A1 (en) | 2019-04-01 | 2022-02-09 | Applied Therapeutics Inc. | Inhibitors of aldose reductase |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
DE3337859A1 (de) * | 1983-01-21 | 1984-07-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von benzthiazolen |
CA1299178C (en) * | 1985-11-07 | 1992-04-21 | Banavara Lakshmana Mylari | Heterocyclic oxophtalazinyl acetic acids |
ES2032749T3 (es) * | 1985-11-07 | 1993-03-01 | Pfizer Inc. | Acidos oxoftalazinil-aceticos heterociclicos. |
JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
EP0322153A3 (en) * | 1987-12-21 | 1990-08-16 | Pfizer Inc. | Heterocyclic oxophtalazinyl acetic acids |
WO1989006651A1 (en) * | 1988-01-19 | 1989-07-27 | Pfizer Inc. | 1h-indazole-3-acetic acids as aldose reductase inhibitors |
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
-
1989
- 1989-05-11 US US07/350,997 patent/US4954629A/en not_active Expired - Lifetime
-
1990
- 1990-04-25 ES ES90304441T patent/ES2063265T3/es not_active Expired - Lifetime
- 1990-04-25 AT AT90304441T patent/ATE103913T1/de not_active IP Right Cessation
- 1990-04-25 DE DE69007846T patent/DE69007846T2/de not_active Expired - Fee Related
- 1990-04-25 DK DK90304441.0T patent/DK0397350T3/da active
- 1990-04-25 EP EP90304441A patent/EP0397350B1/en not_active Expired - Lifetime
- 1990-05-02 RO RO144965A patent/RO107256B1/ro unknown
- 1990-05-04 IE IE162690A patent/IE62591B1/en not_active IP Right Cessation
- 1990-05-06 IL IL114271A patent/IL114271A/en not_active IP Right Cessation
- 1990-05-06 IL IL9430190A patent/IL94301A/en not_active IP Right Cessation
- 1990-05-08 CZ CS902278A patent/CZ281213B6/cs not_active IP Right Cessation
- 1990-05-08 NZ NZ233597A patent/NZ233597A/en unknown
- 1990-05-09 PT PT93985A patent/PT93985B/pt not_active IP Right Cessation
- 1990-05-09 PL PL90285113A patent/PL164427B1/pl unknown
- 1990-05-10 NO NO902071A patent/NO177708C/no not_active IP Right Cessation
- 1990-05-10 HU HU902995A patent/HU212304B/hu not_active IP Right Cessation
- 1990-05-10 ZA ZA903565A patent/ZA903565B/xx unknown
- 1990-05-10 CN CN90102797A patent/CN1025855C/zh not_active Expired - Fee Related
- 1990-05-10 EG EG27690A patent/EG19082A/xx active
- 1990-05-10 DD DD90340590A patent/DD294257A5/de not_active IP Right Cessation
- 1990-05-10 FI FI902333A patent/FI93959C/fi not_active IP Right Cessation
- 1990-05-10 CA CA002016504A patent/CA2016504C/en not_active Expired - Fee Related
- 1990-05-10 AU AU54906/90A patent/AU618898B2/en not_active Ceased
- 1990-05-10 RU SU904743977A patent/RU2014333C1/ru active
- 1990-05-10 AR AR90316824A patent/AR246968A1/es active
- 1990-05-10 YU YU91290A patent/YU91290A/sh unknown
- 1990-05-10 KR KR1019900006579A patent/KR920006419B1/ko not_active IP Right Cessation
- 1990-05-10 BG BG091982A patent/BG50609A3/xx unknown
- 1990-05-11 PH PH40512A patent/PH26567A/en unknown
- 1990-05-11 JP JP2122862A patent/JPH035479A/ja active Granted
- 1990-05-11 MX MX020672A patent/MX167455B/es unknown
-
1991
- 1991-10-28 AU AU86806/91A patent/AU626225B2/en not_active Ceased
-
1992
- 1992-12-31 MX MX9207687A patent/MX9207687A/es not_active IP Right Cessation
-
1995
- 1995-06-22 IL IL11427195A patent/IL114271A0/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL290124A1 (en) | Method of obtaining novel imidazoliloalkenic acids | |
PT83684A (en) | Process for preparing heterocyclyl oxophtalazinyl acetic acids | |
HUT43115A (en) | Process for production of /s/-alpha-methil-aryl acetic acids | |
PT82769A (en) | Process for the preparation of thiazolidin acids derivatives-4 (s)-carboxylics | |
EP0431373A3 (en) | Processes for producing 5-fluorbenzoic acids and their intermediates | |
IL92681A0 (en) | Process and intermediates for the preparation of 4-phenylpiperidines | |
IL89535A0 (en) | Process and novel intermediates for the preparation of 1-cyclopropyl-quinolone-carboxylic acids and their derivatives | |
EG19082A (en) | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
EP0421268A3 (en) | Process for the preparation of polyalkyleneetherglycols containing heteropoly acids | |
EP0227301A3 (en) | Process for the preparation of n-formyl-alpha-l-aspartyl-l-phenylalanine methyl ester | |
EP0543343A3 (en) | Process for the preparation of alpha-hydroxy-beta-aminocarboxylic acids | |
DE3760333D1 (en) | Process for the preparation of alkene carboxylic acids | |
IL84476A0 (en) | Process and intermediates for the synthesis of purin-9-ylalkylenoxy-methyl phosphonic acids | |
DE3663520D1 (en) | Process for the preparation of halogen-thiophene-2-carboxylic acids | |
GB9103134D0 (en) | Process for the preparation of n-acyl-alpha-amino acids | |
EP0247485A3 (en) | Process for the preparation of oxetan-3-carboxylic acids | |
DE3660958D1 (en) | Process for the preparation of unsaturated carboxylate esters | |
PT83238A (en) | Process for the preparation of cyclohexanealkanoic acids | |
GB8803535D0 (en) | Process for preparation of carboxylic acids/esters thereof | |
ZA897782B (en) | Process for the preparation of 7-substituted-hept-6-enoic and-haptanoic acids and derivatives and intermediates thereof | |
HRP940502A2 (en) | Process for the preparation of new substituted alkanediphosphonic acids | |
ZA86235B (en) | Process for the preparation of esters of amino acids | |
GB2181733B (en) | Process for the preparation of insecticidal esters of 2,4 unsaturated acids | |
IL102773A0 (en) | Process for the preparation of omega-arylalkanoic acids | |
AU2883792A (en) | Intermediates and process for the preparation of mevinic acids |